Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon P Connelly

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Nature Communications|February 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Nature|November 19, 2021
CRISPR screens unveil signal hubs for nutrient licensing of T cell immunityLingyun Long, Jun Wei, Seon Ah Lim, et al.
Nature Communications|July 6, 2023
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastomaJie Fang, Shivendra Singh, Changde Cheng, et al.
Nature Biotechnology|June 11, 2026
Large-scale, spatially resolved panoramic CRISPR screening in native tissue environments using Perturb-DBiTAlev Baysoy, Xiaolong Tian, Paul Renauer, et al.
Nature Communications|September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.
Nature|March 26, 2026
Dominant clones leverage developmental epigenomic states to drive ependymomaAlisha S Kardian, Hua Sun, Siri Ippagunta, et al.
Science Advances|July 9, 2020
XAF1 as a modifier of p53 function and cancer susceptibilityEmilia M Pinto, Bonald C Figueiredo, Wenan Chen, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Nature Communications|February 28, 2025
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acidMin Pan, Yinwen Zhang, William C Wright, et al.
Nature|November 19, 2021
CRISPR screens unveil signal hubs for nutrient licensing of T cell immunityLingyun Long, Jun Wei, Seon Ah Lim, et al.
Nature Communications|July 6, 2023
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastomaJie Fang, Shivendra Singh, Changde Cheng, et al.
Nature Biotechnology|June 11, 2026
Large-scale, spatially resolved panoramic CRISPR screening in native tissue environments using Perturb-DBiTAlev Baysoy, Xiaolong Tian, Paul Renauer, et al.
Nature Communications|September 17, 2025
RBM39 degrader invigorates innate immunity to eradicate neuroblastoma despite cancer cell plasticityShivendra Singh, Jie Fang, Hongjian Jin, et al.
Nature|March 26, 2026
Dominant clones leverage developmental epigenomic states to drive ependymomaAlisha S Kardian, Hua Sun, Siri Ippagunta, et al.
Science Advances|July 9, 2020
XAF1 as a modifier of p53 function and cancer susceptibilityEmilia M Pinto, Bonald C Figueiredo, Wenan Chen, et al.
Pageof 5